Denali Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 4 published signal records.
Denali Therapeutics last closed at $19.45 (+4.18%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -6.8×. Its overall grade ranks 442 of 738 stocks in Healthcare.
About this company
Denali Therapeutics last closed at $19.45 (+4.18%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 442/738
Valuation grade B-
Related stocks
- BiogenCustomer
신경퇴행성 질환 파이프라인에서 공동개발·상업화 파트너로 연결
- TakedaCustomer
희귀질환/신경질환 후보물질의 라이선스·공동개발 파트너
- RocheCustomer
알츠하이머 등 CNS 영역에서 협업 가능성이 큰 대형 제약 파트너
About Denali Therapeutics
- What technical signals does Denali Therapeutics (DNLI) have?
- Denali Therapeutics current technical signals: no active technical signal.
- Is Denali Therapeutics a cup-and-handle pattern?
- No. Denali Therapeutics has no valid Cup signal right now.
- What published figures are available for Denali Therapeutics?
- Market cap: $3.03B. Trailing 12 months PER: -6.8×. Latest quarter PBR: 4.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Denali Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.